Gene therapy shows lasting benefit for children with a rare disorder

(MedPage Today) – For children born with severe combined immunodeficiency due to adenosine deaminase deficiency (ADA-SCID), an investigational gene therapy has demonstrated sustained clinical efficacy and safety at a median follow-up of 7.5 years. within…